Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.

FRAMINGHAM, MA — Four people have been charged with ... doing business as “Droga Reis” (Portuguese for “Drug King”). In support of his operation, Reis de Souza allegedly distributed ...

Hearings get underway Wednesday at the Massachusetts State House and in Washington to look into the fungal meningitis outbreak that originated at a Framingham compounding pharmacy. A ...

Pharmacist Barry Cadden, co-owner of the Framingham pharmacy blamed for the ... An inspector later spotted a drawer labeled with the drug’s name, Trypan blue, and asked Cadden to open it.

And Massachusetts ... about conditions at the Framingham, Mass., plant – and the extent of contamination in vials of the steroid methylprednisolone acetate, the drug involved in most of the ...

Maura Healey expanded Massachusetts' gun laws to include ... ghost guns often go hand-in-hand with those involved in drug distribution. Framingham police allege that is the case in last week's ...

Framingham residents can dispose of unwanted medications from 10 a.m. to 2 p.m. on April 26 at the Memorial Building parking lot. The event is part of National Drug Take Back Day, a nationwide ...

FRAMINGHAM, Mass ... They aren't regulated by the FDA. Also Thursday, Massachusetts enacted emergency regulations that, like Markey's bill, aim to prevent compounding pharmacies from being ...

The Food and Drug Administration approved the Framingham, Massachusetts, facility for the production of Fabrazyme, a treatment for Fabry disease, Paris-based Sanofi said today in a statement.